Jim Simons Eledon Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 135,873 shares of ELDN stock, worth $592,406. This represents 0.0% of its overall portfolio holdings.

Number of Shares

135,873

Previous 136,773 0.66%

Holding current value

$592,406

Previous $361,000 6.37%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$2.41 - $3.19 $2,169 - $2,871	-900 Reduced 0.66%	135,873 $338,000
Q2 2024 Aug 09, 2024	BUY	$1.57 - $3.12 $78,035 - $155,076	49,704 Added 57.09%	136,773 $361,000
Q1 2024 May 13, 2024	BUY	$1.54 - $2.13 $27,559 - $38,118	17,896 Added 25.87%	87,069 $179,000
Q4 2023 Feb 13, 2024	BUY	$1.12 - $1.86 $8,064 - $13,392	7,200 Added 11.62%	69,173 $125,000
Q3 2023 Nov 14, 2023	BUY	$1.14 - $1.66 $1,823 - $2,656	1,600 Added 2.65%	61,973 $85,000
Q2 2023 Aug 11, 2023	BUY	$1.34 - $2.85 $37,788 - $80,370	28,200 Added 87.65%	60,373 $83,000
Q1 2023 May 12, 2023	BUY	$2.0 - $3.46 $5,000 - $8,650	2,500 Added 8.43%	32,173 $76,000
Q4 2022 Feb 13, 2023	SELL	$2.17 - $2.75 $4,774 - $6,050	-2,200 Reduced 6.9%	29,673 $68,000
Q3 2022 Nov 14, 2022	SELL	$2.45 - $3.88 $735 - $1,164	-300 Reduced 0.93%	31,873 $88,000
Q2 2022 Aug 12, 2022	BUY	$2.34 - $3.96 $32,057 - $54,252	13,700 Added 74.16%	32,173 $79,000
Q1 2022 May 13, 2022	BUY	$3.06 - $4.89 $14,688 - $23,472	4,800 Added 35.11%	18,473 $73,000
Q4 2021 Feb 11, 2022	SELL	$4.02 - $6.07 $104,479 - $157,759	-25,990 Reduced 65.53%	13,673 $60,000
Q3 2021 Nov 12, 2021	BUY	$5.94 - $8.46 $110,222 - $156,983	18,556 Added 87.91%	39,663 $245,000
Q2 2021 Aug 13, 2021	SELL	$7.62 - $11.75 $45,293 - $69,842	-5,944 Reduced 21.97%	21,107 $167,000
Q1 2021 May 13, 2021	BUY	$9.85 - $19.22 $266,452 - $519,920	27,051 New	27,051 $289,000

Others Institutions Holding ELDN

# of Institutions

Shares Held

18.4M

Call Options Held

Put Options Held

View Full List

About Eledon Pharmaceuticals, Inc.

Ticker ELDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,756,800
Market Cap $60M
Description
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...

More about ELDN

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account